Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Author: Avi Kapoor | March 25, 2024 05:34am

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday.

Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) rose sharply in today’s pre-market trading.

The U.S. FDA approved broad new labels for Esperion's NEXLETOL® and NEXLIZET® to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use.

Esperion Therapeutics shares jumped 12.7% to $2.58 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

Forge Global Holdings, Inc. (NYSE:FRGE) shares gained 22.8% to $2.86 in pre-market trading after gaining 13% on Friday.
Canopy Growth Corporation (NASDAQ:CGC) gained 19.5% to $9.17 in pre-market trading. The German government approved legislation which legalizes the possession and cultivation of cannabis beginning April 1.
Masimo Corporation (NASDAQ:MASI) shares climbed 13.8% to $153.65 in pre-market trading after the company announced it has authorized management to evaluate a proposed separation of its consumer business. The company also reaffirmed its first-quarter and FY24 guidance.
Cronos Group Inc. (NASDAQ:CRON) rose 9.6% to $2.86 in pre-market trading after gaining 9% on Friday.
Nuvation Bio Inc. (NASDAQ:NUVB) gained 8.2% to $2.50 in pre-market trading after gaining 3% on Friday.
Tilray Brands, Inc. (NASDAQ:TLRY) gained 5.2% to $2.43 in pre-market trading after jumping 18% on Friday. Germany approved the legalization of cannabis for adult use.
WK Kellogg Co (NYSE:KLG) rose 4.8% to $19.49 in pre-market trading.
GoodRx Holdings, Inc. (NASDAQ:GDRX) shares climbed 4.1% to $6.85 in pre-market trading. Wells Fargo analyst Stan Berenshteyn upgraded GoodRx from Equal-Weight to Overweight and announced a $10 price target.
Century Aluminum Company (NASDAQ:CENX) shares gained 3.6% to $13.69 in pre-market trading.